Assuntos
Febre de Causa Desconhecida/etiologia , Arterite de Células Gigantes/complicações , Arterite de Células Gigantes/diagnóstico , Tuberculose/complicações , Tuberculose/diagnóstico , Idoso , Antituberculosos/uso terapêutico , Biópsia , Diagnóstico Diferencial , Feminino , Arterite de Células Gigantes/tratamento farmacológico , Humanos , Fígado/microbiologia , Fígado/patologia , Pulmão/diagnóstico por imagem , Pulmão/microbiologia , Masculino , Mycobacterium tuberculosis/isolamento & purificação , Prednisona/uso terapêutico , Artérias Temporais/patologia , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Tuberculose/tratamento farmacológicoRESUMO
OBJECTIVE: Takayasu Arteritis (TA) is a rare disease that mainly affects large elastic arteries. It is more frequently seen in Asia, the Mediterranean basin, South Africa and Latin America. We have characterized its clinical manifestations and identified the cardiovascular mortality predictors in a cohort of 110 Mexican Mestizo patients. MATERIAL AND METHOD: Retrospective review of 110 charts of TA patients complying with the American College of Rheumatology (ACR) criteria, seen in a single hospital between 1976 and 2003. Demographic, clinical, and radiological characteristics were described. With the use of actuarial table analysis at 2, 5, and 10 years, and Kaplan Meier methods applying t function for probability, plus Cox regression analysis, the following factors were identified as mortality predictors: systemic arterial hypertension, coronary heart disease and aortic valve regurgitation. Informed consent and approval from the institutional Internal Review Board (IRB) were obtained. RESULTS: We observed a slowly progressive widespread obstructive arterial disease with cardiovascular (48%), neuro-ophthalmic (36%), and skin morbidity (13%). Systemic hypertension and heart disease were significant mortality predictors. Twenty-six percent of cases died due to myocardial infarction, chronic renal failure, stroke, or surgical complications. CONCLUSION: TA in Mexican Mestizos shows a clinical pattern similar to the one recognized in the Far East. Management strategies must be directed at reducing the identified mortality risk factors.
Assuntos
Indígenas Norte-Americanos , Arterite de Takayasu/etnologia , Adolescente , Adulto , Criança , Estudos de Coortes , Feminino , Humanos , Estimativa de Kaplan-Meier , Masculino , México/epidemiologia , Prognóstico , Estudos Retrospectivos , Arterite de Takayasu/mortalidade , Arterite de Takayasu/fisiopatologia , Adulto JovemRESUMO
The main objective of this study is to describe the presence of infections in patients with pulmonary haemorrhage and systemic lupus erythematosus. Patients with systemic lupus erythematosus and pulmonary haemorrhage were thoroughly evaluated in the first 48 hours with imaging plus bronchoscopy and bronchoalveolar fluid analysis. If needed, videoassisted thoracoscopy and lung biopsy were performed too. In all, search for bacterial, mycobacterial and fungal infections proceeded. Appropriate blood, bronchoalveolar fluid and tissue cultures were taken. Patients were treated with antibiotics and corticosteroids in case of infection. Otherwise, they received initial intravenous methylprednsiolone pulses for 3 days as standard therapy for pulmonary haemorrhage in systemic lupus erythematosus. Additional treatment with immunosuppressives was further decided by the treating physicians. Fourteen events in 13 patients were evaluated. In eight events (57%), an infection was demonstrated. Aetiological agents included Pseudomonas sp. and Aspergillus fumigatus. Four patients died, three of them because of the pulmonary infection and one because of cerebral haemorrhage secondary to severe systemic hypertension, 48 hours after methylprednisolone treatment. Patients with systemic lupus erythematosus and pulmonary haemorrhage have a high prevalence of infections. The influence of pulmonary haemorrhage in the setting of systemic lupus erythematosus needs further study to establish adequate treatment and to reduce the high mortality of this complication.
Assuntos
Hemoptise/complicações , Lúpus Eritematoso Sistêmico/complicações , Infecções Respiratórias/epidemiologia , Adolescente , Adulto , Biópsia , Líquido da Lavagem Broncoalveolar/microbiologia , Broncoscopia , Diagnóstico Diferencial , Feminino , Seguimentos , Hemoptise/diagnóstico , Humanos , Pulmão/patologia , Lúpus Eritematoso Sistêmico/diagnóstico , Masculino , México/epidemiologia , Prevalência , Prognóstico , Estudos Prospectivos , Infecções Respiratórias/diagnóstico , Infecções Respiratórias/etiologia , Fatores de Risco , Taxa de Sobrevida , ToracoscopiaRESUMO
Antineutrophil cytoplasm autoantibodies (ANCA) are essential for the diagnosis of small-vessel vasculitis. Information for and against their usefulness to predict relapse exists. Different approaches, using various methods and definitions, have been used to answer the role of ANCA in predicting disease relapse. Multinational, multicentric prospective studies are needed to address this question using uniform definitions and preferably the best latest tools for ANCA detection.